JP2017509694A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509694A5 JP2017509694A5 JP2016568146A JP2016568146A JP2017509694A5 JP 2017509694 A5 JP2017509694 A5 JP 2017509694A5 JP 2016568146 A JP2016568146 A JP 2016568146A JP 2016568146 A JP2016568146 A JP 2016568146A JP 2017509694 A5 JP2017509694 A5 JP 2017509694A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutical composition
- ring
- disease
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14462004 | 2014-02-07 | ||
| EP14462004.4 | 2014-02-07 | ||
| PCT/HU2015/000014 WO2015118365A1 (en) | 2014-02-07 | 2015-02-09 | Novel use of sigma-1 receptor agonist compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017509694A JP2017509694A (ja) | 2017-04-06 |
| JP2017509694A5 true JP2017509694A5 (enExample) | 2018-03-22 |
| JP6723930B2 JP6723930B2 (ja) | 2020-07-15 |
Family
ID=50241356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016568146A Active JP6723930B2 (ja) | 2014-02-07 | 2015-02-09 | シグマ−１−受容体アゴニスト化合物の新規使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10124006B2 (enExample) |
| EP (1) | EP3104847B8 (enExample) |
| JP (1) | JP6723930B2 (enExample) |
| CN (1) | CN106456578B (enExample) |
| CA (1) | CA2938928C (enExample) |
| DK (1) | DK3104847T3 (enExample) |
| ES (1) | ES2848710T3 (enExample) |
| HR (1) | HRP20210114T1 (enExample) |
| HU (1) | HUE053165T2 (enExample) |
| IL (1) | IL247143B (enExample) |
| PL (1) | PL3104847T3 (enExample) |
| SI (1) | SI3104847T1 (enExample) |
| WO (1) | WO2015118365A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2700448R1 (es) * | 2016-06-07 | 2019-02-26 | Esteve Pharmaceuticals Sa | Uso de ligandos del receptor sigma en la diabetes y el sindrome metabolico |
| MA46898A (fr) * | 2016-11-24 | 2019-10-02 | Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag | Compositions pour la conservation d'organes |
| WO2019079794A1 (en) * | 2017-10-20 | 2019-04-25 | Anavex Life Sciences Corp. | TREATMENT OF CARDIAC DYSFUNCTIONS |
| EP3893892A4 (en) * | 2018-12-12 | 2022-09-14 | Rutgers, the State University of New Jersey | ORGANIC COMPOUNDS |
| US20220117951A1 (en) | 2019-02-14 | 2022-04-21 | Algernon Pharmaceuticals Inc. | Compositions and methods for treating idiopathic pulmonary fibrosis |
| WO2021081624A1 (en) | 2019-10-28 | 2021-05-06 | Algernon Pharmaceuticals Inc. | Use of glutamate 2b receptor antagonists and sigma receptor agonsists as antitussives |
| CN112386679B (zh) * | 2020-11-18 | 2023-05-30 | 徐州医科大学 | 一种包载sigma-1受体的外泌体在制备抗抑郁药物中的应用 |
| US20230263797A1 (en) * | 2021-08-26 | 2023-08-24 | Unm Rainforest Innovations | Mammalian Hybrid Pre-Autophagosomal Structure HyPAS and Compositions and Methods for the Treatment of Coronavirus Infections and Related Disease States |
| WO2024094156A1 (zh) * | 2022-11-04 | 2024-05-10 | 石药集团中奇制药技术（石家庄）有限公司 | 胺类化合物及其用途 |
| JP2024097397A (ja) * | 2023-01-06 | 2024-07-19 | 学校法人関西文理総合学園 | 腎機能改善剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7503310A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| IN186677B (enExample) | 1999-11-12 | 2001-10-20 | Sun Pharmaceutical Ind Ltd | |
| AU3413401A (en) | 2000-02-22 | 2001-09-03 | Daiichi Asubio Pharma Co., Ltd. | Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| CN100509782C (zh) * | 2001-11-13 | 2009-07-08 | 先灵公司 | Nk1拮抗剂 |
| AR039241A1 (es) | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
| CN1688549A (zh) | 2002-08-23 | 2005-10-26 | 麒麟麦酒株式会社 | 具有TGFβ抑制活性的化合物和含所述化合物的药用组合物 |
| GB0715047D0 (en) | 2007-08-02 | 2007-09-12 | Glaxo Group Ltd | Novel Compounds |
| DE102007063535A1 (de) * | 2007-12-21 | 2009-06-25 | Cycnad Gmbh & Co. Kg | Pharmazeutische Zusammensetzung zur Prophylaxe und/oder symptomatischen Behandlung von zystischer Fibrose |
| WO2010048716A1 (en) | 2008-10-29 | 2010-05-06 | Pacific Therapeutics Ltd. | Composition and method for treating fibrosis |
| US20120040004A1 (en) | 2009-01-28 | 2012-02-16 | Region Midtjylland | Treatment of radiation-induced fibrosis |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| US20110288101A1 (en) * | 2010-05-21 | 2011-11-24 | Alcon Research, Ltd. | Surgical compositions containing sigma-receptor agonists |
| WO2013103317A1 (en) * | 2012-01-05 | 2013-07-11 | Clanotech Ab | Quinoline compounds which are anti-angiogenic integrin alpha5 betal inhibitors for use in the treatment of fibrosis or fibrosis-related diseases |
-
2015
- 2015-02-09 US US15/117,233 patent/US10124006B2/en active Active
- 2015-02-09 CN CN201580018235.6A patent/CN106456578B/zh active Active
- 2015-02-09 EP EP15715809.8A patent/EP3104847B8/en active Active
- 2015-02-09 PL PL15715809T patent/PL3104847T3/pl unknown
- 2015-02-09 JP JP2016568146A patent/JP6723930B2/ja active Active
- 2015-02-09 CA CA2938928A patent/CA2938928C/en active Active
- 2015-02-09 HR HRP20210114TT patent/HRP20210114T1/hr unknown
- 2015-02-09 WO PCT/HU2015/000014 patent/WO2015118365A1/en not_active Ceased
- 2015-02-09 SI SI201531492T patent/SI3104847T1/sl unknown
- 2015-02-09 HU HUE15715809A patent/HUE053165T2/hu unknown
- 2015-02-09 DK DK15715809.8T patent/DK3104847T3/da active
- 2015-02-09 ES ES15715809T patent/ES2848710T3/es active Active
-
2016
- 2016-08-07 IL IL24714316A patent/IL247143B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| HRP20210114T1 (hr) | Nova primjena spoja agonista sigma-1 receptora | |
| RU2485131C2 (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой и содержащие их противогрибковые средства | |
| RU2018106914A (ru) | 1,3,4,-оксадизоламидное производное соединение в качестве ингибитора гистондеацетилазы 6 и содержащая его фармацевтическая композиция | |
| JP2019537605A5 (enExample) | ||
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| RU2012158142A (ru) | Противоопухолевое средство, задействующее соединения с ингибирующим эффектом к киназам в комбинации | |
| RU2017145930A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| JP2016512203A5 (enExample) | ||
| RU2008112184A (ru) | Производное тиазола | |
| JP2014502979A5 (enExample) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| RU2013155586A (ru) | [1,3]оксазины | |
| JP2019501130A5 (enExample) | ||
| RU2011146363A (ru) | Производные n-ацил-n-фенилпиперазина, используемые (кроме того) для профилактики или лечения диабета | |
| JP2005536475A5 (enExample) | ||
| JP2007502806A5 (enExample) | ||
| RU2018112993A (ru) | Соединения и способы для ингибирования JAK | |
| JP2019507179A5 (enExample) | ||
| RU2018136888A (ru) | Нафтиридины в качестве антагонистов интегрина | |
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения | |
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака | |
| CN107635975B (zh) | Dgat2抑制剂 | |
| RU2010134411A (ru) | Фенилацетамидное производное | |
| RU2016104844A (ru) | Производные n-мочевино замещенных аминокислот как модуляторы формил-пептидного рецептора |